The market has been high on Collegium Pharmaceutical Inc (COLL) stock recently. COLL gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With COLL Stock Today?
Collegium Pharmaceutical Inc (COLL) stock is trading at $20.83 as of 1:39 PM on Wednesday, Sep 30, an increase of $0.95, or 4.78% from the previous closing price of $19.88. The stock has traded between $19.91 and $20.90 so far today. Volume today is less active than usual. So far 216,731 shares have traded compared to average volume of 319,529 shares.
To see the top 5 stocks in the Drug Manufacturers - Specialty & Generic industry click here.
More About Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing and dissolving. Its product Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone.
Click Here to get the full Stock Score Report on Collegium Pharmaceutical Inc (COLL) Stock.
